CT scans predict chemo penetration and effectiveness in new study; Oramed wins oral diabetes treatment patent in Australia;

> In a new study from the University of Texas, CT scans have shown to be effective at reflecting how well chemotherapy will penetrate a pancreatic tumor and predicting how well a treatment would work. More

> Oramed won its third patent in Australia for the oral administration of exenatide, a diabetes treatment. Release

> Orexo teamed up with UnitedHealth Group and OptumRx for coverage and reimbursement of its sublingual opioid dependence treatment, Zubzolv. Release